These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 436143

  • 1. [Treating gout with benzbromarone (author's transl)].
    Bosmanský K, Trnavský K.
    Cas Lek Cesk; 1979 Feb 02; 118(5):153-6. PubMed ID: 436143
    [No Abstract] [Full Text] [Related]

  • 2. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
    Mertz DP.
    Dtsch Med Wochenschr; 1976 Aug 27; 101(35):1288-92. PubMed ID: 782809
    [No Abstract] [Full Text] [Related]

  • 3. [Long-term therapy with benzbromarone in uric arthritis].
    Bröll H, Sochor H, Tausch G, Eberl R.
    Wien Med Wochenschr; 1975 Sep 19; 125(28):546-8. PubMed ID: 816095
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
    Matzkies F, Berg G.
    Dtsch Med Wochenschr; 1976 Oct 22; 101(43):1568-70. PubMed ID: 991731
    [Abstract] [Full Text] [Related]

  • 5. [Benzbromarone in the treatment of gout].
    Kawenoki-Minc E, Brzozowska-Jurkowska AM.
    Reumatologia; 1980 Oct 22; 18(1):61-7. PubMed ID: 6994191
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks].
    Brzozowska-Jurkowska AM.
    Reumatologia; 1980 Oct 22; 18(3):287-92. PubMed ID: 6999575
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP.
    Med Klin; 1977 Apr 15; 72(15):664-8. PubMed ID: 857138
    [Abstract] [Full Text] [Related]

  • 8. [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].
    Mertz DP, Borner K.
    Med Welt; 1983 Sep 09; 34(36):974-9. PubMed ID: 6633222
    [No Abstract] [Full Text] [Related]

  • 9. Ten years' experience with benzbromarone in the management of gout and hyperuricaemia.
    Masbernard A, Giudicelli CP.
    S Afr Med J; 1981 May 09; 59(20):701-6. PubMed ID: 7221794
    [Abstract] [Full Text] [Related]

  • 10. [Allomaron in hyperuricemia and gout].
    Barsom S.
    ZFA (Stuttgart); 1979 Aug 31; 55(24):1336-40. PubMed ID: 539082
    [No Abstract] [Full Text] [Related]

  • 11. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K, Trnavský K.
    Z Rheumatol; 1979 Aug 31; 38(9-10):342-8. PubMed ID: 525067
    [Abstract] [Full Text] [Related]

  • 12. [A new drug therapy for gout and hyperuricemia. Long term results].
    Masbernard A, Giudicelli CP.
    Sem Hop Ther; 1976 Aug 31; 52(7-8):369-74. PubMed ID: 996556
    [No Abstract] [Full Text] [Related]

  • 13. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R, Bresnik W, Müller MM.
    Fortschr Med; 1979 Nov 22; 97(44):2057-61. PubMed ID: 511087
    [Abstract] [Full Text] [Related]

  • 14. [Results obtained with long-term benzbromarone therapy (author's transl)].
    Bresnik W, Müller MM.
    Wien Klin Wochenschr; 1974 May 17; 86(10):283-7. PubMed ID: 4428763
    [No Abstract] [Full Text] [Related]

  • 15. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
    Mertz DP.
    MMW Munch Med Wochenschr; 1978 Oct 20; 120(42):1387-90. PubMed ID: 101792
    [Abstract] [Full Text] [Related]

  • 16. [Pathogenesis and treatment of fast-induced hyperuricemia using benzbromarone].
    Schräpler P, Schulz E.
    Med Welt; 1976 Mar 19; 27(12):575-81. PubMed ID: 1263801
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of gout with alternate-day antihyperuricemic drugs (author's transl)].
    Nishizawa T, Nishida Y, Masuda T, Akaoka I.
    Ryumachi; 1978 Mar 19; 18(2):104-11. PubMed ID: 663791
    [No Abstract] [Full Text] [Related]

  • 18. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
    Fortschr Med; 1979 May 03; 97(17):835-6. PubMed ID: 437646
    [No Abstract] [Full Text] [Related]

  • 19. [Indications for and methods of allopurinol-benzbromarone combination therapy in the treatment of hyperuricemic metabolic disorders].
    Heidelmann G, Burck G, Dauterstedt W, Heinrich JJ, Ohlmer R.
    Z Arztl Fortbild (Jena); 1982 Mar 01; 76(5):177-81. PubMed ID: 6896252
    [No Abstract] [Full Text] [Related]

  • 20. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F, Neuwirth R, Berg G.
    Fortschr Med; 1976 Sep 16; 94(26):1427-9. PubMed ID: 976920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.